Biomarkers of the Future Conference: From bedside to practice
The BMF 2021 will bring together a number of international key opinion leaders, all experts within in their individual fields of life science research, along with young fellows, senior researchers and industry partners, all focusing on biomarker discovery and research. The meeting will be directed to the application of high-throughput targeted proteomics as a key tool to understand biology and pathophysiology, as well as identify protein biomarkers for early diagnosis and progression of our major complex diseases.
Due to travel restrictions, the conference will take place exceptionally in a virtual format using a custom-made, state-of-the-art platform to maintain the high quality scientific content, the networking opportunities and the young fellows competition.
Tuesday 23rd November 2021
Biomarkers are eagerly needed to reduce global cardiovascular in women Birgit Vogel – Mount Sinai Morningside
Biomarkers are eagerly needed in Cardio-oncology Alain Cohen-Solal – University of Paris
Wednesday 24th November 2021
Integrating proteomics with other omics for clinical insights Claudia Langenberg – University of Cambridge
Omics in the follow-up of heart failure patients Isabella Kardys – Erasmus University Medical Centre
Next generation plasma proteome profiling Mathias Uhlén – Royal Institute of Technology